Investment group Mercia Technologies said it had made an additional £2.0m direct investment in pain and central nervous system product developer Medherant.
Sub-prime lender Non-Standard Financial said its loan book had grown since the start of the year, while impairment rates had fallen, keeping it 'optimistic' for...